Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease.
Ethan MooreMax V WohlauerJames DoroshMahmood KabeilRafael D MalgorLeigh A O'BanionGabriel Lopez-PenaRiley GilletteKathryn ColbornRobert F CuffLeah LuceroAmna AliIssam KoleilatPaola BatarsehSonia TalathiAksim RiveraMisty D HumphriesKevin LyNikolai HarrounBrigitte K SmithAnna M Darelli-AndersonAsad ChoudhryEric HammondMichael CostanzaVipul KhetarpaulAshley CosentinoJacob WatsonRana AfifiNicolas J MouawadTze-Woei TanMel SharafuddinJudith P QuevedoReggie NkansahPalcah ShibaleSherene ShalhubJudith C LinPublished in: Vascular (2024)
Interventions may be safely delayed for patients with venous disease requiring elective surgical intervention during the COVID-19 pandemic. This finding supports the American College of Surgeons' recommendations for the management of elective vascular surgical procedures. Office-based labs may be safe locations for continued treatment when resources are limited. Although the interventions can be safely postponed, the negative impact on quality of life warrants further investigation.